and a second for the Serum Institute of India (5II) — which is manufacturing its own version of the vaccine under license — and its Canadian partner Verity Pharmaceuticals." Meanwhile, the AP (3/29, Gillies) reports Canada "received its first shipment of AstraZeneca this month - 500,000 doses from India," and Axios (3